Physician profile
Leslie Touger
NPI 1992764765
$1,018.07
in general payments reported to CMS, 2019-2025
19 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $45.82 · 2021: $166 · 2022: $53.74 · 2023: $121 · 2024: $143 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.75 | 2019-2025 | |
| Abbvie INC. | $154.88 | 2021-2025 | Lupron Depot |
| Novo Nordisk INC | $141.17 | 2019-2024 | Sogroya |
| Medtronic, INC. | $92.51 | 2021-2022 | |
| Genzyme Corporation | $75.30 | 2025 | |
| Tandem Diabetes Care, INC. | $60.83 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $46.25 | 2021-2023 | Freestyle Libre 3 |
| Intuity Medical INC | $45.22 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Insulet Corporation | $40.37 | 2019-2023 | Omnipod |
| Tolmar, INC. | $33.44 | 2023-2024 | |
| Dexcom, INC. | $32.12 | 2019-2021 | |
| Ascendis Pharma Endocrinology INC | $19.14 | 2024 | |
| Ferring Pharmaceuticals INC. | $18.95 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.03 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.34 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eton Pharmaceuticals, INC. | $15.09 | 2021 | |
| Companion Medical, INC. | $14.66 | 2020 | |
| Medtronic Minimed, INC. | $13.40 | 2020 | |
| Lilly USA, LLC | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Touger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.